Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
- PMID: 32555145
- PMCID: PMC7298436
- DOI: 10.1038/s41392-020-0195-x
Targeting the entry step of SARS-CoV-2: a promising therapeutic approach
Figures
Comment on
-
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. Cell. 2020. PMID: 32142651 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- No. 81420108027/National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund)/International
- No. 81420108027/National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund)/International
- No. 81420108027/National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund (NSFC-Yunnan Joint Fund)/International
LinkOut - more resources
Full Text Sources
Miscellaneous
